Clinical outcomes up to 9 years after [18F]flutemetamol amyloid-PET in a symptomatic memory clinic population

Clinical outcomes up to 9 years after [18F]flutemetamol amyloid-PET in a symptomatic memory clinic population

Abstract Background Previous studies demonstrated increases in diagnostic confidence and change in patient management after amyloid-PET. However, studies investigating longitudinal outcomes over an extended period of time are limited. Therefore, we aimed to investigate clinical outcomes up to 9 year...

תיאור מלא

מידע ביבליוגרפי
Main Authors: Lyduine E. Collij, Gill Farrar, Marissa Zwan, Elsmarieke van de Giessen, Rik Ossenkoppele, Frederik Barkhof, Annemieke J. M. Rozemuller, Yolande A. L. Pijnenburg, Wiesje M. van der Flier, Femke Bouwman
פורמט: Article
שפה:English
יצא לאור: BMC 2023-11-01
סדרה:Alzheimer’s Research & Therapy
נושאים:
[18F]flutemetamol amyloid-PET
Early-onset dementia
Diagnosis
Survival
Neuropathology
גישה מקוונת:https://doi.org/10.1186/s13195-023-01351-1

אינטרנט

https://doi.org/10.1186/s13195-023-01351-1

פריטים דומים